Therapeutic agent

Ivermectin

Also known as: Ivermectin

ModerateEvidence level
1Registered trials
2Conditions
1Study references

Evidence Summary

Evidence Level
Moderate
Mechanism
Enrollment: Actual, Sponsor Type: Other, Unknown / General
Safety
Limited specific safety data in these populations. Review full prescribing information and consult specialist. Many agents used off-label or investigational.
Dosing
See linked studies/trials for reported doses and durations; typical protocols vary widely.
Investigational for listed conditions. 1 associated trial(s) and 1 study reference(s) in current data. Review primary sources and consult specialists before use.

Clinical Trials

1 trial(s) registered

NCT IDTitlePhaseStatus
NCT04510194COVID-OUT: Early Outpatient Treatment for SARS-CoV-2 Infection (COVID-19)Phase 3Completed

Key Studies / References